708
Participants
Start Date
January 31, 2013
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
BI 10773
Empagliflozin active
BI 10773 Placebo
Empagliflozin placebo
BI 10773 / BI 1356
Empagliflozin / Linagliptin 25/5 mg Dose FDC active
BI 10773
Empagliflozin active
BI 10773 / BI 1356
Empagliflozin / Linagliptin 10/5 mg Dose FDC active
BI 10773 / BI 1356 Placebo
Empagliflozin / Linagliptin 10/5 mg Dose placebo FDC
BI 10773
Empagliflozin active
BI 10773
Empagliflozin active
BI 10773
Empagliflozin active
BI 10773 / BI 1356 Placebo
Empagliflozin / Linagliptin 25/5 mg Dose FDC placebo
BI 10773 Placebo
Empagliflozin placebo
BI 10773 / BI 1356 Placebo
Empagliflozin / Linagliptin 10/5 mg Dose FDC placebo
BI 10773
Empagliflozin active
BI 10773 / BI 1356 Placebo
Empagliflozin / Linagliptin 25/5 mg Dose FDC placebo
1275.10.01019 Boehringer Ingelheim Investigational Site, Chino
1275.10.01008 Boehringer Ingelheim Investigational Site, Huntington Beach
1275.10.01003 Boehringer Ingelheim Investigational Site, San Diego
1275.10.01024 Boehringer Ingelheim Investigational Site, San Diego
1275.10.01002 Boehringer Ingelheim Investigational Site, Sylmar
1275.10.01011 Boehringer Ingelheim Investigational Site, Miami
1275.10.01009 Boehringer Ingelheim Investigational Site, Orlando
1275.10.01023 Boehringer Ingelheim Investigational Site, Oviedo
1275.10.01006 Boehringer Ingelheim Investigational Site, Tamarac
1275.10.01017 Boehringer Ingelheim Investigational Site, Conyers
1275.10.01016 Boehringer Ingelheim Investigational Site, Snellville
1275.10.01012 Boehringer Ingelheim Investigational Site, Avon
1275.10.01013 Boehringer Ingelheim Investigational Site, Muncie
1275.10.01010 Boehringer Ingelheim Investigational Site, Elkton
1275.10.01001 Boehringer Ingelheim Investigational Site, Stevensville
1275.10.01007 Boehringer Ingelheim Investigational Site, Salisbury
1275.10.01005 Boehringer Ingelheim Investigational Site, Bismarck
1275.10.01020 Boehringer Ingelheim Investigational Site, Oklahoma City
1275.10.01022 Boehringer Ingelheim Investigational Site, Pittsburgh
1275.10.01021 Boehringer Ingelheim Investigational Site, Union
1275.10.01014 Boehringer Ingelheim Investigational Site, North Richland Hills
1275.10.01018 Boehringer Ingelheim Investigational Site, Draper
1275.10.01015 Boehringer Ingelheim Investigational Site, Richmond
1275.10.01025 Boehringer Ingelheim Investigational Site, Virginia Beach
1275.10.54005 Boehringer Ingelheim Investigational Site, Caba
1275.10.54012 Boehringer Ingelheim Investigational Site, Caba
1275.10.54002 Boehringer Ingelheim Investigational Site, Capital Federal
1275.10.54007 Boehringer Ingelheim Investigational Site, Capital Federal
1275.10.54013 Boehringer Ingelheim Investigational Site, Capital Federal
1275.10.54006 Boehringer Ingelheim Investigational Site, Córdoba
1275.10.54008 Boehringer Ingelheim Investigational Site, Córdoba
1275.10.54011 Boehringer Ingelheim Investigational Site, Córdoba
1275.10.54003 Boehringer Ingelheim Investigational Site, Godoy Cruz, Mendoza
1275.10.54009 Boehringer Ingelheim Investigational Site, Mar del Plata
1275.10.54004 Boehringer Ingelheim Investigational Site, Salta
1275.10.54001 Boehringer Ingelheim Investigational Site, San Isidro
1275.10.54010 Boehringer Ingelheim Investigational Site, Zárate
1275.10.61008 Boehringer Ingelheim Investigational Site, Cardiff
1275.10.61002 Boehringer Ingelheim Investigational Site, East Ringwood
1275.10.61001 Boehringer Ingelheim Investigational Site, Heidelberg Heights
1275.10.61009 Boehringer Ingelheim Investigational Site, Mirrabooka
1275.10.02004 Boehringer Ingelheim Investigational Site, Edmonton
1275.10.02001 Boehringer Ingelheim Investigational Site, Red Deer
1275.10.02003 Boehringer Ingelheim Investigational Site, Chilliwack
1275.10.02009 Boehringer Ingelheim Investigational Site, Coquitlam
1275.10.02012 Boehringer Ingelheim Investigational Site, Vancouver
1275.10.02006 Boehringer Ingelheim Investigational Site, Winnipeg
1275.10.02008 Boehringer Ingelheim Investigational Site, Winnipeg
1275.10.02005 Boehringer Ingelheim Investigational Site, Moncton
1275.10.02013 Boehringer Ingelheim Investigational Site, Burlington
1275.10.02007 Boehringer Ingelheim Investigational Site, Greater Sudbury
1275.10.02002 Boehringer Ingelheim Investigational Site, Strathroy
1275.10.02011 Boehringer Ingelheim Investigational Site, Drummondville
1275.10.02010 Boehringer Ingelheim Investigational Site, Montreal
1275.10.34014 Boehringer Ingelheim Investigational Site, Ávila
1275.10.49007 Boehringer Ingelheim Investigational Site, Aßlar
1275.10.49014 Boehringer Ingelheim Investigational Site, Berlin
1275.10.49004 Boehringer Ingelheim Investigational Site, Cologne
1275.10.49016 Boehringer Ingelheim Investigational Site, Elsterwerda
1275.10.49012 Boehringer Ingelheim Investigational Site, Hamburg
1275.10.49005 Boehringer Ingelheim Investigational Site, Hatten
1275.10.49008 Boehringer Ingelheim Investigational Site, Kiel Kronshagen
1275.10.49010 Boehringer Ingelheim Investigational Site, Lübeck
1275.10.49003 Boehringer Ingelheim Investigational Site, Münster
1275.10.49006 Boehringer Ingelheim Investigational Site, Pirna
1275.10.49013 Boehringer Ingelheim Investigational Site, Saint Ingbert/Oberwürzbach
1275.10.49001 Boehringer Ingelheim Investigational Site, Unterschneidheim
1275.10.49015 Boehringer Ingelheim Investigational Site, Wangen
1275.10.39005 Boehringer Ingelheim Investigational Site, Ancona
1275.10.39006 Boehringer Ingelheim Investigational Site, Catania
1275.10.39009 Boehringer Ingelheim Investigational Site, Catania
1275.10.39014 Boehringer Ingelheim Investigational Site, Catania
1275.10.39007 Boehringer Ingelheim Investigational Site, Latina
1275.10.39012 Boehringer Ingelheim Investigational Site, Milan
1275.10.39013 Boehringer Ingelheim Investigational Site, Milan
1275.10.39015 Boehringer Ingelheim Investigational Site, Olbia (OT)
1275.10.39016 Boehringer Ingelheim Investigational Site, Orbassano (TO)
1275.10.39004 Boehringer Ingelheim Investigational Site, Palermo
1275.10.39003 Boehringer Ingelheim Investigational Site, Pistoia
1275.10.39008 Boehringer Ingelheim Investigational Site, Roma
1275.10.39001 Boehringer Ingelheim Investigational Site, Sesto San Giovanni (MI)
1275.10.39010 Boehringer Ingelheim Investigational Site, Siena
1275.10.39011 Boehringer Ingelheim Investigational Site, Terni
1275.10.35104 Boehringer Ingelheim Investigational Site, Cantanhede
1275.10.35112 Boehringer Ingelheim Investigational Site, Porto
1275.10.35103 Boehringer Ingelheim Investigational Site, Sandim
1275.10.35105 Boehringer Ingelheim Investigational Site, Tornada
1275.10.35108 Boehringer Ingelheim Investigational Site, Valadares
1275.10.35101 Boehringer Ingelheim Investigational Site, Vila Nova de Gaia
1275.10.07004 Boehringer Ingelheim Investigational Site, Chelyabinsk
1275.10.07003 Boehringer Ingelheim Investigational Site, Saint Petersburg
1275.10.07006 Boehringer Ingelheim Investigational Site, Saint Petersburg
1275.10.07001 Boehringer Ingelheim Investigational Site, Saratov
1275.10.07005 Boehringer Ingelheim Investigational Site, Saratov
1275.10.07002 Boehringer Ingelheim Investigational Site, Yaroslavl
1275.10.34003 Boehringer Ingelheim Investigational Site, Barcelona
1275.10.34004 Boehringer Ingelheim Investigational Site, Canet de Mar
1275.10.34008 Boehringer Ingelheim Investigational Site, Centelles
1275.10.34009 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat (Barcelona)
1275.10.34012 Boehringer Ingelheim Investigational Site, La Roca del Vallès
1275.10.34006 Boehringer Ingelheim Investigational Site, Madrid
1275.10.34011 Boehringer Ingelheim Investigational Site, Mataró
1275.10.34001 Boehringer Ingelheim Investigational Site, Málaga
1275.10.34010 Boehringer Ingelheim Investigational Site, Málaga
1275.10.34013 Boehringer Ingelheim Investigational Site, Pineda de Mar
1275.10.34002 Boehringer Ingelheim Investigational Site, Sabadell
1275.10.34005 Boehringer Ingelheim Investigational Site, Tarragona
1275.10.38006 Boehringer Ingelheim Investigational Site, Chernivtsi
1275.10.38007 Boehringer Ingelheim Investigational Site, Dnipro
1275.10.38002 Boehringer Ingelheim Investigational Site, Kiev
1275.10.38003 Boehringer Ingelheim Investigational Site, Kiev
1275.10.38004 Boehringer Ingelheim Investigational Site, Lviv
1275.10.38001 Boehringer Ingelheim Investigational Site, Vinnitsa
1275.10.38005 Boehringer Ingelheim Investigational Site, Zhytomyr
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Boehringer Ingelheim
INDUSTRY